02/18/2025
7:15 PM | HURLY STEPHEN A (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Morris Charles Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Powell Fred M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | Dhingra Kapil (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | Backstrom Jay T. (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | Kiener Peter A (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
WILSON KAREN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
6:29 PM | LAVA Therapeutics (Issuer)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:26 AM | Dhingra Kapil (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:28 AM | Backstrom Jay T. (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:29 AM | Kiener Peter A (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:31 AM | LAVA Therapeutics (Issuer)
Noble James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:32 AM | LAVA Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:34 AM | LAVA Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:35 AM | LAVA Therapeutics (Issuer)
WILSON KAREN J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:19 AM | HURLY STEPHEN A (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:20 AM | LAVA Therapeutics (Issuer)
Powell Fred M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:21 AM | LAVA Therapeutics (Issuer)
Morris Charles Q (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
7:45 AM | LAVA Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:05 AM | LAVA Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
6:09 PM | LAVA Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
